Pieter Westerduin

Title: Pieter Westerduin: Innovator in Pharmaceutical Chemistry

Introduction

Pieter Westerduin is a notable inventor based in Lichtaart, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate orexin receptors. His work is essential for advancing treatments for various disorders, including insomnia and depression.

Latest Patents

Westerduin holds a patent for synthetic methods of making (2H-1, 2, 3-triazol-2-yl) phenyl compounds as orexin receptor modulators. The patent describes processes for preparing (((3aR,6aS)-5-(4,6-dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanone. This compound is valuable for commercial manufacturing and may be useful in pharmaceutical compositions aimed at treating conditions mediated by orexin activity.

Career Highlights

Westerduin is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work focuses on innovative solutions that address critical health issues. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in drug development.

Collaborations

Westerduin has collaborated with notable colleagues, including Dominique Paul M Depré and Kiran Matcha. These partnerships enhance the research and development efforts within the pharmaceutical sector.

Conclusion

Pieter Westerduin is a prominent figure in pharmaceutical innovation, with a focus on orexin receptor modulators. His contributions are vital for the development of new treatments for insomnia and depression. His work exemplifies the impact of inventive research in improving healthcare outcomes.